| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |